EPARs - Cholestagel//colesevelam

FICHA FARMACOLÓGICA de colesevelam. Contiene la Monografía en distintos idiomas (de la Comunidad Económica Europea), así como la discusión científica que sustenta su aprobación terapéutica. Para acceder a la monografía en idioma español, hacer doble clik en la sigla (es) en la fila que se sitúa más abajo del centro de la página oficial. Cerasale. ABRIL 19, 2009.-

abrir aquí:
EPARs for authorised medicinal products for human use - Cholestagel

Active Substance
colesevelam
International Nonproprietary Name or Common Name
colesevelam
Pharmaco-therapeutic Group
Bile acid sequestrants
ATC Code
C10AC04

Therapeutic Indication:
Cholestagel co-administered with a 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitor (statin) is indicated as adjunctive therapy to diet to provide an additive reduction in low-density lipoprotein cholesterol (LDL-C) levels in adult patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone.

Cholestagel as monotherapy is indicated as adjunctive therapy to diet for reduction of elevated total-cholesterol and LDL-C in adult patients with isolated primary hypercholesterolaemia, in whom a statin is considered inappropriate or is not well tolerated.

Date of issue of Marketing Authorisation valid throughout the European Union
10 March 2004